Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.4m
Position in Universe th / 6853

BRIEF-Juniper Pharmaceuticals Says Signs Definitive Agreement To Be Acquired By Catalent For $11.50 Per Share In Cash

Tue 3rd July, 2018 8:18am
July 3 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O :
    * JUNIPER PHARMACEUTICALS SIGNS DEFINITIVE AGREEMENT TO BE
ACQUIRED BY CATALENT, INC. FOR $11.50 PER SHARE IN CASH
    * JUNIPER PHARMACEUTICALS - DEFINITIVE AGREEMENT WITH
CATALENT FOR
CATALENT TO BUY ALL OF OUTSTANDING SHARES OF CO AT $11.50 PER
SHARE IN CASH
    * TRANSACTION REPRESENTS A TOTAL EQUITY VALUE OF
APPROXIMATELY
$139.6 MILLION ON A FULLY-DILUTED BASIS
    * TRANSACTION APPROVED UNANIMOUSLY BY JUNIPER BOARD OF
DIRECTORS
    * ROTHSCHILD & CO IS ACTING AS FINANCIAL ADVISOR AND GOODWIN
PROCTER LLP IS ACTING AS LEGAL COUNSEL TO JUNIPER

Source text for Eikon:  ID:nPn1GyThfa 
Further company coverage:  JNP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.